Addison's Disease: Difference between revisions
No edit summary |
No edit summary |
||
Line 14: | Line 14: | ||
== Characteristics/Clinical Presentation == | == Characteristics/Clinical Presentation == | ||
Addison’s disease will develop insidiously, with the signs of the disease not developing “until at least 90% of both glands is destroyed and the levels of circulating glucocorticoids and mineralocorticoids are significantly decreased.”2 Some of the clinical signs and symptoms of Addison’s disease include: | Addison’s disease will develop insidiously, with the signs of the disease not developing “until at least 90% of both glands is destroyed and the levels of circulating glucocorticoids and mineralocorticoids are significantly decreased.”2 Some of the clinical signs and symptoms of Addison’s disease include: | ||
•<span class="Apple-tab-span" style="white-space:pre"> </span>Darkened pigmentation of the skin, due to increased secretion of melanin-secreting hormone (MSH) corresponding with | •<span class="Apple-tab-span" style="white-space:pre"> </span>Darkened pigmentation of the skin, due to increased secretion of melanin-secreting hormone (MSH) corresponding with increased secretion of ACTH, which is released to try to stimulate the work of the adrenal glands1,2, | ||
•<span class="Apple-tab-span" style="white-space:pre"> </span>Slowly developing weakness and fatigue2,3 | •<span class="Apple-tab-span" style="white-space:pre"> </span>Slowly developing weakness and fatigue2,3 | ||
•<span class="Apple-tab-span" style="white-space:pre"> </span>Hypotension due to increased sodium excretion from decreased aldosterone secretion1,2,3 | •<span class="Apple-tab-span" style="white-space:pre"> </span>Hypotension due to increased sodium excretion from decreased aldosterone secretion1,2,3 | ||
•<span class="Apple-tab-span" style="white-space:pre"> </span>Severe abdominal, low back, or leg pain1 | •<span class="Apple-tab-span" style="white-space:pre"> </span>Severe abdominal, low back, or leg pain1 | ||
•<span class="Apple-tab-span" style="white-space:pre"> </span>Gastrointestinal disturbances such as nausea, vomiting, anorexia, weight loss, and diarrhea2,3 | •<span class="Apple-tab-span" style="white-space:pre"> </span>Gastrointestinal disturbances such as nausea, vomiting, anorexia, weight loss, and diarrhea2,3 | ||
•<span class="Apple-tab-span" style="white-space:pre"> </span>Hypoglycemia due to decreased glucocorticoids causing decreased gluconeogenesis1,2 | •<span class="Apple-tab-span" style="white-space:pre"> </span>Hypoglycemia due to decreased glucocorticoids causing decreased gluconeogenesis1,2 | ||
•<span class="Apple-tab-span" style="white-space:pre"> </span>Decreased stress tolerance (infections, trauma, surgery, etc.)1,2 | •<span class="Apple-tab-span" style="white-space:pre"> </span>Decreased stress tolerance (infections, trauma, surgery, etc.)1,2 | ||
•<span class="Apple-tab-span" style="white-space:pre"> </span>Salt craving | •<span class="Apple-tab-span" style="white-space:pre"> </span>Salt craving | ||
<br> | <br> |
Revision as of 00:03, 8 March 2010
Original Editors - Students from Bellarmine University's Pathophysiology of Complex Patient Problems project.
Lead Editors - Your name will be added here if you are a lead editor on this page. Read more.
Definition/Description[edit | edit source]
Addison’s disease is another name for primary chronic adrenal insufficiency. It is a condition where the adrenal cortex (the outer layer of the adrenal gland that produces mineralocorticoids, glucocorticoids, and androgens) is progressively destroyed, resulting in decreased secretions of the hormones. Cortisol, a glucocorticoid, and aldosterone, a mineralcorticoid, are the primary hormones that are decreased with this disease, causing body wide metabolic disorders and fluid imbalances.
Prevalence[edit | edit source]
Addison’s disease occurs in about 4 out of 100,000 Americans each year. Even though it is seen throughout the lifespan in both genders, it most commonly occurs in middle-aged white females.
Characteristics/Clinical Presentation[edit | edit source]
Addison’s disease will develop insidiously, with the signs of the disease not developing “until at least 90% of both glands is destroyed and the levels of circulating glucocorticoids and mineralocorticoids are significantly decreased.”2 Some of the clinical signs and symptoms of Addison’s disease include:
• Darkened pigmentation of the skin, due to increased secretion of melanin-secreting hormone (MSH) corresponding with increased secretion of ACTH, which is released to try to stimulate the work of the adrenal glands1,2,
• Slowly developing weakness and fatigue2,3
• Hypotension due to increased sodium excretion from decreased aldosterone secretion1,2,3
• Severe abdominal, low back, or leg pain1
• Gastrointestinal disturbances such as nausea, vomiting, anorexia, weight loss, and diarrhea2,3
• Hypoglycemia due to decreased glucocorticoids causing decreased gluconeogenesis1,2
• Decreased stress tolerance (infections, trauma, surgery, etc.)1,2
• Salt craving
Associated Co-morbidities[edit | edit source]
add text here
Medications[edit | edit source]
add text here
Diagnostic Tests/Lab Tests/Lab Values[edit | edit source]
add text here
Causes[edit | edit source]
add text here
Systemic Involvement[edit | edit source]
add text here
Medical Management (current best evidence)[edit | edit source]
add text here
Physical Therapy Management (current best evidence)[edit | edit source]
add text here
Alternative/Holistic Management (current best evidence)[edit | edit source]
add text here
Differential Diagnosis[edit | edit source]
add text here
Case Reports[edit | edit source]
add links to case studies here (case studies should be added on new pages using the case study template)
Resources
[edit | edit source]
add appropriate resources here
Recent Related Research (from Pubmed)[edit | edit source]
see tutorial on Adding PubMed Feed
Extension:RSS -- Error: Not a valid URL: Feed goes here!!|charset=UTF-8|short|max=10
References[edit | edit source]
see adding references tutorial.